RxDoctor Payments Data
★ My doctorsLook up a doctor →

Jason Siefferman

Interventional Pain Medicine · New York, NYNPI 1841440617

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (51.8%), speaking fees and consulting fees — rather than concentrated in one kind of arrangement. 49 manufacturers reported payments, led by Merz Pharmaceuticals, LLC at 51.8% of the total. 2025 is the largest year on record at $15,197, more than ten times the $263 reported in 2019. Among interventional pain medicine clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$29,046in general payments, 2019–2025

Across 522 payments — averaging $55.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merz Pharmaceuticals, LLC$15K
  • AbbVie$3K
  • SPR Therapeutics, Inc$2K
  • Boston Scientific$1K
  • Lundbeck LLC$951
  • Abbott$615
  • plus $6K from 43 others

What the payments were for

  • Consulting fees$8803%
  • Speaking & faculty fees$12,98045%
  • Food & beverage$15,05052%
  • Education$1360%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Merz Pharmaceuticals, LLC55$15,059
AbbVie(2 entities)155$3,325
SPR Therapeutics, Inc8$1,629
Boston Scientific20$1,225
Lundbeck LLC52$951
Abbott10$615
Johnson & Johnson(2 entities)20$603
UCB, Inc.18$595
Pfizer17$467
Nevro Corp.3$428
Medtronic6$375
Azurity Pharmaceuticals, Inc.15$342
Amgen(2 entities)10$326
Lilly USA, LLC17$264
AstraZeneca(2 entities)6$263
Collegium Pharmaceutical, Inc.13$254
Axsome Therapeutics, Inc.9$238
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC16$194
Teva Pharmaceuticals USA, Inc.8$174
Arbor Pharmaceuticals, Inc.10$164
Vertos Medical, Inc.1$161
Painteq LLC2$153
Genentech USA, Inc.7$145
Ortho Systems1$136
Biohaven Pharmaceutical Holding Company Ltd.7$117
Radius Health, Inc.3$96
Si-bone, Inc.3$93
Organon3$78
MDD US Operations, LLC3$52
Scilex Pharmaceuticals Inc.2$47
Biohaven Pharmaceuticals, Inc.2$47
Blueprint Medicines Corporation1$37
Epimed International, Inc2$35
Neuronetics, Inc.1$34
Pacira Pharmaceuticals Incorporated1$30
Almatica Pharma LLC2$30
Biodelivery Sciences International, Inc.1$26
Kyowa Kirin, Inc.1$23
Sobi, Inc1$23
Metacel Pharmaceuticals LLC1$23
Amneal Pharmaceuticals LLC1$21
Zimmer Biomet1$21
GRT US Holding, Inc.1$21
Biogen1$20
Kowa Pharmaceuticals America, Inc.1$20
Relievant Medsystems, Inc.1$19
Zyla Life Sciences, Inc.1$18
Fidia Pharma USA Inc.1$16
Vertex1$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$29,046 in reported general payments places this provider in the 90th percentile of 132 interventional pain medicine providers in New York.

See all interventional pain medicine providers in New York →

Other interventional pain medicine in New York

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →